JP2012516693A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516693A5
JP2012516693A5 JP2011548765A JP2011548765A JP2012516693A5 JP 2012516693 A5 JP2012516693 A5 JP 2012516693A5 JP 2011548765 A JP2011548765 A JP 2011548765A JP 2011548765 A JP2011548765 A JP 2011548765A JP 2012516693 A5 JP2012516693 A5 JP 2012516693A5
Authority
JP
Japan
Prior art keywords
polypeptide
sequence
amino acids
variant
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516693A (ja
JP5746053B2 (ja
Filing date
Publication date
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from GB0901928A external-priority patent/GB0901928D0/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Priority claimed from GB0917871A external-priority patent/GB0917871D0/en
Application filed filed Critical
Priority claimed from PCT/GB2010/000198 external-priority patent/WO2010089554A1/en
Publication of JP2012516693A publication Critical patent/JP2012516693A/ja
Publication of JP2012516693A5 publication Critical patent/JP2012516693A5/ja
Publication of JP5746053B2 publication Critical patent/JP5746053B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548765A 2009-02-05 2010-02-05 ワクチン用ペプチド Expired - Fee Related JP5746053B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901928.2 2009-02-05
GB0901927.4 2009-02-05
GB0901928A GB0901928D0 (en) 2009-02-05 2009-02-05 Peptides for vaccine
GB0912578.2 2009-07-20
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
GBPCT/GB2009/01995 2009-08-14
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production
GB0917871A GB0917871D0 (en) 2009-10-12 2009-10-12 Peptides for vaccine
GB0917871.6 2009-10-12
PCT/GB2010/000198 WO2010089554A1 (en) 2009-02-05 2010-02-05 Peptides for vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015094636A Division JP6215252B2 (ja) 2009-02-05 2015-05-07 ワクチン用ペプチド

Publications (3)

Publication Number Publication Date
JP2012516693A JP2012516693A (ja) 2012-07-26
JP2012516693A5 true JP2012516693A5 (enExample) 2013-03-21
JP5746053B2 JP5746053B2 (ja) 2015-07-08

Family

ID=42082585

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011548765A Expired - Fee Related JP5746053B2 (ja) 2009-02-05 2010-02-05 ワクチン用ペプチド
JP2015094636A Expired - Fee Related JP6215252B2 (ja) 2009-02-05 2015-05-07 ワクチン用ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015094636A Expired - Fee Related JP6215252B2 (ja) 2009-02-05 2015-05-07 ワクチン用ペプチド

Country Status (23)

Country Link
US (2) US8753644B2 (enExample)
EP (2) EP2393830B8 (enExample)
JP (2) JP5746053B2 (enExample)
KR (1) KR20110111307A (enExample)
CN (2) CN102307893B (enExample)
AU (1) AU2010212193B2 (enExample)
BR (1) BRPI1008802A2 (enExample)
CA (1) CA2751500A1 (enExample)
DK (1) DK2393830T3 (enExample)
EA (1) EA020792B1 (enExample)
ES (1) ES2532759T3 (enExample)
GB (1) GB2469894B (enExample)
HK (1) HK1212358A1 (enExample)
HR (1) HRP20150317T1 (enExample)
IL (1) IL214257A (enExample)
MX (1) MX2011008179A (enExample)
NZ (1) NZ594268A (enExample)
PL (1) PL2393830T3 (enExample)
PT (1) PT2393830E (enExample)
SG (1) SG173523A1 (enExample)
SI (1) SI2393830T1 (enExample)
WO (1) WO2010089554A1 (enExample)
ZA (1) ZA201105436B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2393830T1 (sl) * 2009-02-05 2015-04-30 Circassia Limited Travni peptidi za cepivo
CN107320734A (zh) * 2011-04-29 2017-11-07 西莱克塔生物科技公司 从合成纳米载体中控制释放免疫抑制剂
CN105307641A (zh) 2013-05-03 2016-02-03 西莱克塔生物科技公司 用于降低不期望体液免疫应答的给药组合
EA201790551A1 (ru) 2014-09-07 2017-07-31 Селекта Байосайенсиз, Инк. Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору
WO2017004561A1 (en) 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
EP4599848A3 (en) 2017-03-11 2025-12-03 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN108802216B (zh) * 2018-05-23 2021-04-16 山东出入境检验检疫局检验检疫技术中心 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法
US12553041B2 (en) 2019-06-04 2026-02-17 Cartesian Therapeutics Inc. Formulations and doses of pegylated uricase

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2089735C (en) 1990-08-17 2008-03-18 Mohan Bir Singh Ryegrass pollen allergen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
EP0665888B2 (en) 1991-08-16 2007-07-25 The University Of Melbourne Ryegrass pollen allergen
EP0668915A1 (en) 1991-11-15 1995-08-30 The University Of Melbourne Protein allergens of the species cynodon dactylon
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
ATE283281T1 (de) 1992-08-14 2004-12-15 Univ Melbourne T-zell epitope des raygraspollen-allergens
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US6214358B1 (en) 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
NZ263913A (en) * 1993-03-12 1997-10-24 Immulogic Pharma Corp Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use
FI960629L (fi) * 1993-08-13 1996-04-12 Immulogic Pharma Corp Raiheinäsiitepöly allergeenin T-soluepitoopit
US5968526A (en) 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
GB9412714D0 (en) 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
AU3338195A (en) * 1994-07-26 1996-02-22 University Of Manitoba Allergen peptides
US7112333B1 (en) 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
AT402505B (de) 1995-08-02 1997-06-25 Biomay Prod & Handel Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
JP2002500198A (ja) 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
DE19823097A1 (de) * 1998-05-22 1999-11-25 Max Planck Gesellschaft Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
WO2003047618A2 (en) 2001-12-05 2003-06-12 Circassia Limited Immunotherapeutic methods and systems
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
DE102004035337A1 (de) * 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2006132607A1 (en) 2005-06-10 2006-12-14 National University Of Singapore Mutant allergen(s)
DE202005009990U1 (de) * 2005-06-25 2006-11-02 Hengst Gmbh & Co.Kg Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
DK2119450T3 (da) 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
US20110038881A1 (en) 2007-05-09 2011-02-17 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
SI2393830T1 (sl) * 2009-02-05 2015-04-30 Circassia Limited Travni peptidi za cepivo

Similar Documents

Publication Publication Date Title
JP2010536333A5 (enExample)
KR102236829B1 (ko) 헵시딘 유사체 및 이의 용도
CN114729022A (zh) 缀合的铁调素模拟物
EP3749345A1 (en) Conjugated hepcidin mimetics
JP2015504052A5 (enExample)
AU2007240313A1 (en) GLP-1 compounds
HRP20100662T1 (hr) Peptidi za desenzibilizaciju protiv alergena
CN107075574A (zh) 铁调素和微型铁调素类似物及其用途
KR20010041238A (ko) 인슐린의 펩티드 동족체를 사용하는 당뇨병의 치료 방법
JP2011528332A (ja) 哺乳動物ベータ・デフェンシンを用いた炎症性疾患の処置
SI2797950T1 (en) Fusion protein against cancer
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
CN114028553A (zh) 包括免疫原性肽组合的药物组合物
Svendsen et al. Amino acid sequence homology between human and bovine low molecular weight folate binding protein isolated from milk
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
TW201710287A (zh) 蛋白酶抗性之脂化肽
CN110831957B (zh) Apoc-ii模拟肽
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2008050133A2 (en) Inhibition of beta-amyloid aggregation
US8361964B2 (en) Growth hormone releasing factor (GRF) analogs and uses thereof
EP2802598B1 (en) Peptides and peptide derivatives based on xenin
US9850281B2 (en) Cladosporium peptides
RU2014107838A (ru) ГИПОАЛЛЕРГИЧЕСКИЕ ВАРИАНТЫ Mal d 1, ГЛАВНОГО АЛЛЕРГЕНА Malus domectica
JP2023520989A (ja) 1型糖尿病の予防および治療に有用なtレジトープ構築物
WO2013179043A1 (en) Alternaria peptides